Screener
Arcus Biosciences RCUS Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$91M— | -$128M-14.3% | -$106M-12.8% | -$135M-46.7% | $0+100% | ||
| $3M+50.0% | $2M-33.3% | $3M0.0% | $2M0.0% | $2M0.0% | ||
| $15M0.0% | $19M+18.8% | $15M-11.8% | $14M-26.3% | $15M-25.0% | ||
| -$119M+10.5% | -$138M-4.5% | -$120M-20.0% | -$97M— | -$133M-41.5% | ||
| $0— | $0-100% | $1M0.0% | —— | —— | ||
| $52M-62.0% | $114M+256% | —— | $79M+372% | $137M— | ||
| —— | —— | $12.25M— | $12.25M-73.9% | $12.25M— | ||
| $16M-69.2% | $3M-97.9% | $286M— | $8M-83.3% | $52M+2,500% | ||
| -$51M-191% | -$21M-150% | —— | —— | $56M— | ||
| -$119M+10.5% | -$138M-3.8% | -$121M-19.8% | -$97M— | -$133M-41.5% |
FAQ
- How much cash does Arcus Biosciences generate?
- Arcus Biosciences (RCUS) generated -$474.0M in operating cash flow over the trailing twelve months.
- What is Arcus Biosciences's free cash flow?
- After $2.0M of capital expenditures, Arcus Biosciences's free cash flow was -$475.0M over the trailing twelve months, down 3.0% year over year.
- Where does Arcus Biosciences's cash flow data come from?
- Every line is extracted from Arcus Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
